Coeptis Therapeutics Holdings, Inc. Warrants (COEPW)

• Market cap: $83.6K
• 1 day: 12.73%
• 5 days: 45.88%
• 1 month: 2.90%
• 3 months: 222.08%
• 6 months: -11.11%
• Year to date: -30.73%
• 1 year: 9.25%
• 5 years: -95.87%
• 10 years: -95.87%
• Sector: Healthcare
• Industry: Biotechnology

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.58% less ownership

Funds ownership: 2.5% [Q4 2024] → 1.92% (-0.58%) [Q1 2025]

8% less funds holding

Funds holding: 13 [Q4 2024] → 12 (-1) [Q1 2025]

59% less capital invested

Capital invested by funds: $21.4K [Q4 2024] → $8.72K (-$12.6K) [Q1 2025]

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3